Andere Sprachen Seikagaku Corporation

Aktien

887446

JP3414000004

4548

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 02.05.2024			% 5 Tage	% 1. Jan.
741 ^JPY	-0.40%		+0.54%	-2.63%

08.04.	Ferring Pharmaceuticals Inc. präsentiert auf der ASIPP 2024 Daten zur Wirksamkeit und Sicherheit des Phase-3-Prüfpräparats SI-6603 bei lumbalen Bandscheibenvorfällen	CI
2023	Seikagaku Corporation meldet Ergebnis für das am 31. März 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	09.04.
Seikagaku : Announces an Academic Conference Presentation on SI-6603 by Licensee Ferring Pharmaceuticals Inc.	09.04.
Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	08.04.
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2023	10.11.
Seikagaku : Consolidated Financial Results (Summary) for the First Three Months of Fiscal 2023 (Three-Month Period Ended June 30, 2023)	04.08.23
Seikagaku : Financial Results for the First Quarter of Fiscal Year 2023	04.08.23
Ferring Announces Positive Topline Phase 3 Results for SI-6603, an Investigational Treatment for Lumbar Disc Herniation	29.05.23
Seikagaku : Announces the Topline Results from a Phase III Clinical Study (Additional Study) in the U.S. for SI-6603, a Treatment for Lumbar Disc Herniation	26.05.23
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	22.05.23
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	19.05.23
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2022(Year Ended March 31, 2023)	12.05.23
Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	12.05.23
Seikagaku : Financial Results for the Fiscal Year 2022	12.05.23
Seikagaku : Consolidated Financial Results for the Thrid Quarter of Fiscal year 2022	08.02.23
Seikagaku : Financial Results for the Third Quarter of Fiscal Year 2022	08.02.23
Seikagaku : announces Results of Acquisition of Treasury Stocks and its Completion	28.12.22
Tranche Update on Seikagaku Corporation's Equity Buyback Plan announced on May 13, 2022.	26.12.22
Seikagaku Corporation's Equity Buyback announced on May 13, 2022, has closed with 1,725,700 shares, representing 3.10% for ¥1,499.99 million.	23.12.22
Seikagaku : announces the Progress of Acquisition of Treasury Stocks	01.12.22
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2022	18.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Seikagaku Corporation

Aktien

887446

JP3414000004

4548

Andere Sprachen

Filter